ClinicalTrials.gg
Enrolling by invitationNCT07729735Updated Jul 27, 2026

Physiotherapy After Breast Reduction Surgery

An interventional study of Physiotherapy in Breast, Posture and Mammaplasty, sponsored by Istanbul Rumeli University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Istanbul Rumeli University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey — 98 open to participants now, 111 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Turkey.

Planned enrollment
250th of 311
40 · median 60
Started
2026
with 67 others
No phase
309 of 393
75 open now
Primary completion
2026-08
later than 62 of 110 live
Registered
329th of 393
by date

Among the 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey, this one is the 250th largest by planned enrollment of the 311 interventional ones that give a count, is one of 68 that started in 2026, is one of 309 with no phase, reaches primary completion later than 62 of the 110 other live ones, and was the 329th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

98 of the 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey are open now. Recruiting first, the newest first:

93 more — sign in →

All 98 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 50 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey, or all of them as a file.
02

Study summary

Background and Purpose:

Breast reduction surgery is a major procedure that can lead to post-operative pain, postural deviations, and a temporary decline in quality of life.This clinical study aims to investigate the efficacy of early-phase physical therapy on pain management, postural alignment, and overall quality of life in female patients following breast reduction surgery.

Study Design and Participants:

This is a controlled clinical trial involving 40 female participants aged 18 to 50 who have undergone their first breast reduction surgery. Participants are divided into two groups: an intervention group (n=20) and a control group (n=20). The study follows a pre-test and post-test design to evaluate outcomes before and after a three-week intervention period.

Intervention Protocol:

The intervention group receives a comprehensive physical therapy program starting one week post-operation. The program is conducted three days a week for three weeks, with sessions lasting 40 to 60 minutes The protocol includes:

Postural and cervical exercises Scapular stabilization and manual therapy Scar massage and Transcutaneous Electrical Nerve Stimulation (TENS) as needed A structured home exercise program.

Outcome Measures:

Primary and secondary outcomes are assessed through various clinical tools:

Pain:Visual Analog Scale (VAS) Posture: New York Posture Test, measurements of scapular protraction and cervical anterior tilt Mobility:Shoulder and cervical Range of Motion (ROM) Quality of Life and Health: SF-12, BREAST-Q, and Pittsburgh Sleep Quality Index (PSQI)

Expected Results:

The study anticipates that the early-phase physical therapy group will demonstrate a significant reduction in pain, improved postural alignment, and a higher quality of life compared to the control group.

03

Conditions studied

  • Breast
  • Posture
  • Mammaplasty
  • Sleep Quality

Keywords

  • mammaplasty
  • pain
  • posture
  • breast
  • sleep quality
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 18 and 50 years of age
  • Having undergone aesthetic breast reduction surgery
  • Having a complication-free postoperative period
  • Agreeing to participate in the study voluntarily and having signed the form

Exclusion criteria

Exclusion Criteria:

  1. Oncological History:

    Those who have been diagnosed with breast cancer in the pre-operative or per-operative period, or those with a history of radiotherapy/chemotherapy to the breast area,

  2. Lymphovenous Disorders: Those with lymphedema in the upper extremity or vascular insufficiency that may severely affect lymphatic drainage,
  3. Musculoskeletal and Nervous System Pathologies: Those with orthopedic diseases such as severe scoliosis, ankylosing spondylitis, or neurological diseases such as brachial plexus lesions that may affect posture analysis and shoulder mobility,
  4. Systemic Diseases: Those with uncontrolled Diabetes Mellitus, which directly negatively affects wound healing, or those with active connective tissue diseases,
  5. Exercise : Patients with cardiopulmonary failure or severe cognitive impairment that would prevent participation in the physiotherapy protocol.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Physiotherapy

    Exercise programme

    Other: Physiotherapy

  • No intervention
    Control Group

    No intervention.

Interventions

  • OtherPhysiotherapy

    The participants will attend a physiotherapy programme. The programme includes some exercises.

06

What researchers measure

Primary outcomes

  1. Breast-Q Reduction Module Score

    Breast-related satisfaction will be assessed using the BREAST-Q Reduction Module.

    Time frame: Baseline (preoperative) and 4 weeks after treatment

Secondary outcomes

  1. Posture Evaluation

    New York Posture Rating Test score will be assessed.

    Time frame: Baseline and 4 weeks after treatment

  2. Pain Intensity (VAS)

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS). The scale ranges from 0 (no pain) to 10 (unbearable pain). Participants will mark their pain level on the scale, and the distance in centimeters will be recorded.

    Time frame: Baseline (preoperative) and 4 weeks after treatment

  3. Quality of Life (SF-12)

    Health-related quality of life will be assessed using the SF-12 questionnaire.

    Time frame: Baseline and 4 weeks after treatment

  4. Pittsburgh Sleep Quality Index Total Score

    Total PSQI score will be assessed.

    Time frame: Baseline and 4 weeks after treatment

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Aug 2026, 0 months later.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 0 months is below that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2026
First posted
Jul 27, 2026
StartEst.
Jul 23, 2026
Primary completionEst.
Aug 10, 2026
CompletionEst.
Aug 25, 2026
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07729735
Lead sponsor
Istanbul Rumeli University
Responsible party
Ozden Baskan (Assistant Professor, Istanbul Rumeli University) — Principal investigator
First posted
Jul 27, 2026
Start date
Jul 23, 2026 (estimated)
Primary completion
Aug 10, 2026 (estimated)
Completion
Aug 25, 2026 (estimated)
Last update
Jul 27, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion